Related Experiment Video
Updated: Jun 10, 2025

Transuterine Fetal Tracheal Occlusion Model in Mice
Published on: February 5, 2021
Prenatal diagnosis and risk stratification of congenital diaphragmatic hernia
Nimrah Abbasi1, Sami Backley2, Greg Ryan1
1Ontario Fetal Centre & Fetal Medicine Unit, Department of Obstetrics & Gynaecology, Mount Sinai Hospital PLM, University of Toronto, Toronto, Ontario, Canada.
Insights
Congenital diaphragmatic hernia (CDH) is a rare birth defect. Early diagnosis and expert care improve infant outcomes and manage long-term health challenges.
Area of Science:
- Medical Genetics
- Neonatal Surgery
- Fetal Medicine
Background:
- Congenital diaphragmatic hernia (CDH) is a rare, heterogeneous birth defect with significant variability in severity.
- While survival rates approach 80% in high-income nations for isolated CDH, over half of infants experience long-term morbidities.
- Effective management requires understanding prognostic factors and optimizing neonatal care.
Purpose of the Study:
- To highlight the importance of advanced antenatal imaging for prognostication and risk stratification in CDH.
- To emphasize the need for multidisciplinary expertise in managing CDH cases.
- To inform counseling for expectant parents regarding potential outcomes and management options.
Main Methods:
- Utilizing advanced antenatal imaging (ultrasound, MRI) for severity prognostication.
- Comprehensive genetic testing to identify associated abnormalities.
- Risk stratification based on prenatal diagnosis, gestational age, defect characteristics, and delivery center expertise.
Main Results:
- Prenatal diagnosis and advanced imaging enable accurate prognostication of CDH severity.
- Risk stratification informs optimal neonatal management, fetal intervention considerations, and parental counseling.
- Factors like gestational age, defect size, lung volume, and herniation extent influence prognosis.
Conclusions:
- Optimizing outcomes for CDH necessitates early prenatal diagnosis and referral to specialized multidisciplinary centers.
- Accurate fetal imaging and genetic testing are crucial for predicting disease severity and setting realistic expectations.
- Inclusive counseling for parents of all backgrounds is essential for informed decision-making and care planning.
Abstract:
Congenital diaphragmatic hernia (CDH) is a rare heterogenous disorder with varying degrees of severity. Infant survival rates in high-income countries are approaching 80% in isolated CDH; however, over 50% will have long-term morbidities. Advanced antenatal imaging, including ultrasound and magnetic resonance imaging, has made it possible to prognosticate severity of CDH and to stratify risk when counseling expectant parents. Risk stratification can also better prepare healthcare teams to enable optimal neonatal management, and provide options for fetal intervention or, where legally permitted, pregnancy termination. Factors that may affect the immediate and long-term prognosis for CDH include prenatal diagnosis, gestational age at detection and delivery, side of the defect, presence of additional structural or genetic abnormalities, defect size, estimation of fetal lung volume, the extent of visceral herniation, and the delivery center's experience in caring for neonates with CDH. Optimizing the outcome for families and infants begins with an early prenatal diagnosis followed by referral to a diverse and inclusive multidisciplinary center with CDH expertise. Prediction of disease severity is supported by accurate fetal imaging and comprehensive genetic testing, and allows the care team to provide realistic outcome expectations during the counseling of expectant parents of all racial and ethnic backgrounds.
Related Concept Videos
Teratogenicity
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Mitral Valve Prolapse III: Nursing Management

